Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma
about
Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma
description
im Februar 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2016
@uk
name
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@en
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@nl
type
label
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@en
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@nl
prefLabel
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@en
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@nl
P2093
P2860
P1433
P1476
Lenalidomide with low- or inte ...... relapsed or refractory myeloma
@en
P2093
Despoina Kalapanida
Dimitrios Christoulas
Evangelos Eleutherakis-Papaiakovou
Evangelos Terpos
Flora Zagouri
Magdalini Migkou
Maria Gavriatopoulou
Maria Roussou
Nikolaos Kanellias
P2860
P304
P356
10.3109/10428194.2016.1151513
P577
2016-02-25T00:00:00Z